Medicare Enrolled

Dr. Lloyd Hatton, APRN

Psychiatric/Mental Health Nurse Practitioner · Sherman, TX
Low-engagement
121 W LAMBERTH RD STE A, Sherman, TX 75092
9038926700
In practice since 2020 (6 years)
NPI: 1972138170 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hatton from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hatton? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hatton

Dr. Lloyd Hatton is a psychiatric/mental health nurse practitioner in Sherman, TX, with 6 years in practice.

Between the years covered by Open Payments, Dr. Hatton received a total of $8,742 from 32 pharmaceutical and/or device companies across 567 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatric/mental health nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hatton is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice$ $8,742 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$8,742
Total received (2021-2024)
Avg $2,186/year across 4 years
Top 3% in TX for psychiatric/mental health nurse practitioner
32
Companies
567
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,742 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,915
2023
$2,523
2022
$2,110
2021
$2,195

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,131
Janssen Pharmaceuticals, Inc
$985
Otsuka America Pharmaceutical, Inc.
$908
ITI, Inc.
$657
Teva Pharmaceuticals USA, Inc.
$624
Lundbeck LLC
$543
Sunovion Pharmaceuticals Inc.
$521
Neurocrine Biosciences, Inc.
$495
Corium, LLC
$360
Alkermes, Inc.
$298
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$266
AbbVie Inc.
$230
Neos Therapeutics, LP
$216
Indivior Inc.
$208
Takeda Pharmaceuticals U.S.A., Inc.
$182
Axsome Therapeutics, Inc.
$162
Almatica Pharma LLC
$138
IDORSIA PHARMACEUTICALS US INC
$119
Noven Therapeutics, LLC
$111
Ironshore Pharmaceuticals Inc.
$95
Avanir Pharmaceuticals, Inc.
$74
Eisai Inc.
$72
Merck Sharp & Dohme LLC
$51
Supernus Pharmaceuticals, Inc.
$40
IRONSHORE PHARMACEUTICALS INC.
$39
Bausch Health US, LLC
$38
Corium, Inc.
$36
Harmony Biosciences LLC
$34
Neuronetics, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$32
Vanda Pharmaceuticals Inc.
$26
HARMONY BIOSCIENCES LLC
$19
Top 3 companies account for 34.6% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · CAPLYTA · CITALOPRAM · COBENFY · COTEMPLA XR-ODT · Cotempla XR-ODT · Dayvigo · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY · NUEDEXTA · Nuedexta · PERSERIS · QELBREE · QULIPTA · QUVIVIQ · REXULTI · SERTRALINE HCL · SPRAVATO · SUBLOCADE · Sunosi · TRINTELLIX · UZEDY · VIVITROL · VRAYLAR · WAKIX · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for psychiatric/mental health nurse practitioner in TX.

Looking for a psychiatric/mental health nurse practitioner in Sherman?
Compare psychiatric/mental health nurse practitioners in the Sherman area by procedure volume, costs, and industry payment transparency.
Browse psychiatric/mental health nurse practitioners nearby

Geographic Context

Psychiatric/Mental Health Nurse Practitioners within 10 mi
20
Per 100K population
14.3
County median income
$70,455
Nearest hospital
WILSON N JONES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hatton is a psychiatric/mental health nurse practitioner, and high industry engagement (low-engagement, top 3%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Hatton receive payments from pharmaceutical companies?
Yes. Dr. Hatton received a total of $8,742 from 32 companies across 567 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Hatton) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →